Navigation Links
Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors

SEATTLE--(BUSINESS WIRE)--Jun 1, 2007 - Introgen Therapeutics, Inc. (NASDAQ:INGN) reported promising Phase 1/2 clinical data with INGN 241, the Company's novel investigational mda-7/IL-24 tumor suppressor agent, in patients with advanced solid tumors.

The data (Abstract #380), which were presented today at the annual meeting of the American Society of Gene Therapy, showed that in this 22-patient trial, INGN 241 induced killing in all treated tumors, including in those patients who failed prior therapy with other anti-cancer agents. INGN 241 was well tolerated, and a maximum tolerated dose was not reached. Tumor growth control was observed in 44 percent of treated tumors. Two of five patients treated at the highest dose showed objective responses (greater than 50 percent reduction in tumor size). Increases in the number of immune cells known to mediate anti-tumor effects were also observed in all patients, consistent with the immune-stimulating activity of INGN 241.

Although INGN 241 was administered directly to tumors, evidence of distant biologic activity was observed, suggesting that this therapy may have utility in treating primary tumors as well as metastatic disease. INGN 241 treatment in combination with radiotherapy is being evaluated in an ongoing Phase 3 trial in solid tumors, including patients with head and neck cancer.

"These data are particularly encouraging because they demonstrate INGN 241 has clinical activity even in patients who have failed previous therapies," said Sunil Chada, Ph.D., associate vice president, Clinical Research and Development at Introgen.

INGN 241 Shown to Restore Platinum Sensitivity in Preclinical Studies

Data from preclinical studies of INGN 241 also were presented (Abstract #197) that evaluated the ability of INGN 241 to restore cisplatin sensitivity to ovarian cancer cells that are cisplatin-resistant. The results showed that INGN 241 effecti
'"/>




Page: 1 2 3

Related medicine technology :

1. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
2. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
3. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
4. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
5. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
10. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
(Date:7/4/2015)... BARCELONA , España, July 4, 2015 /PRNewswire/ ... SIR-Spheres® Y-90 a la quimioterapia de primera línea ... en el hígado (mCRC) extiende la supervivencia libre ... pacientes con cáncer colorrectal metastásico no resecable (mCRC) ... la mayor mejora en la supervivencia libre de ...
(Date:7/4/2015)... BARCELONA , Spanje, July 4, 2015 ... SIR-Spheres® Y-90 harsmicrosferen aan eerstelijns chemotherapie voor ... de lever (mCRC) verlengt de progressievrije overleving ... met niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die ... grootste verbetering gezien in progressievrije overleving (PFS) ...
(Date:7/4/2015)... Adding SIR-Spheres® Y-90 resin ... metastatic colorectal cancer in the liver (mCRC) further ... Patients with unresectable metastatic colorectal cancer (mCRC) that ... greatest improvement in Progression-Free Survival (PFS) in the ... microspheres to a current first-line chemotherapy regimen, according ...
Breaking Medicine Technology:El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
... 2011 BD Biosciences, a segment of BD (Becton, ... new BD Falcon™ Multi-Flask, a multi-layer cell culture device ... easily and more efficiently. Currently, most ... new BD Falcon Multi-Flask, available in both three- and ...
... Thousands of jobs in Texas supported by the biopharmaceutical ... such as imposing new taxes in the Medicare prescription ... From research to technical work, manufacturing to construction ... services, the biopharmaceutical sector supports a broad array of ...
Cached Medicine Technology:BD Biosciences Introduces New Device Designed to Increase Cell Growth and Cell Culture Productivity 2Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies 2Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies 3
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... When a hacker gains access to someone’s ... and at the office. On Wednesday, July 1st, the FTC issued a scam alert ... part of a verification process for a password reset instigated by the hacker. All ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project ... technical sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), ... most highly respected and well established national certification organization for renewable energy professionals. ...
(Date:7/3/2015)... , ... July 04, 2015 , ... The Harvest Hope Food Bank will ... Four local AlignLife offices in the area of Greenville SC are making it ... be made by patients only. They are asking for donations from the public as well. ...
(Date:7/3/2015)... Angeles, CA (PRWEB) , ... July 03, 2015 ... ... was opened for enrollment on July 2nd creating a buzz of media attention. ... has been published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people ...
(Date:7/3/2015)... ... July 03, 2015 , ... On June 30th SEO authority ... training system called "Page One Engine" . The program, which has been ... reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2
... polymer, fitted with molecular pincers of carefully tailored structure, ... can be used for fabrication of sensitive and selective ... the near future also in gases. Moreover, the polymer ... for therapeutic purposes. The collaboration of researchers of ...
... tripled in the United States between 1999 and 2006, ... heroin overdoses combined. Hospitalizations and emergency room visits related ... name Oxycontin) and hydrocodone (Vicodin) also increased dramatically in ... the August issue of Health Affairs describes ...
... Goodwin HealthDay Reporter , WEDNESDAY, Aug. 3 ... certain markers in the blood called "autoantibodies" is showing ... blood test correctly detected Alzheimer,s disease in people already ... accuracy, according to the researchers. The test could also ...
... Society of America (GSA) the nation,s largest interdisciplinary organization ... Ferraro, PhD, of Purdue University as the 2011 recipient of ... given to individuals who have not only fostered excellence in ... of their mentoring, and whose inspiration is sought by students ...
... A Mayo Clinic orthopedic surgeon suspects that the nagging ... knees may be different from what men encounter, and ... study to explore the question. The Society for Women,s ... (ISIS) Network on Musculoskeletal Health has awarded a group ...
... Scientists at Cold Spring Harbor Laboratory (CSHL) and five other ... to identify a new potential treatment for acute myeloid leukemia ... 3, the scientists have pinpointed a protein called Brd4 as ... that is currently incurable in 70% of patients. Using a ...
Cached Medicine News:Health News:Polymer's hunt for nicotine 2Health News:Polymer's hunt for nicotine 3Health News:Group Health establishes major initiative to prevent opioid abuse and overdose 2Health News:Group Health establishes major initiative to prevent opioid abuse and overdose 3Health News:Another Blood Test for Alzheimer's Shows Promise 2Health News:Another Blood Test for Alzheimer's Shows Promise 3Health News:Another Blood Test for Alzheimer's Shows Promise 4Health News:Ferraro to receive GSA's 2011 Distinguished Mentorship in Gerontology Award 2Health News:Mayo Clinic examines why knee osteoarthritis afflicts more women than men 2Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 2Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 3Health News:Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia 4
... This comfortable lightweight brace is ... and distal ulnar fractures. The anatomically ... soft tissue compression for optimal control ... wrist and elbow motion is permitted ...
... Dorsal Blocking Splint is constructed of a durable ... protects the flexor tendons of the hand and ... tissue development in the later stages of the ... on the hand and positions the wrist at ...
Bunnell Finger Knuckle-Bender to flex the proximal interpalangeal joint....
... lateral deviation of the finger joints. Lined ... non-slip fit. FingerSled splints can be worn ... with Osteoarthritis, for correction following injury to ... the fingers. Use after surgery to repair ...
Medicine Products: